Wave Life Sciences Ltd. (WVE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Wave Life Sciences Ltd., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -14.03x | -17.63x | -9.32x | -3.41x | -1.33x | -2.06x |
| P/B Ratio | 5.45x | 8.16x | 13.52x | -12.24x | 5.01x | 3.41x |
| P/S Ratio | 67.10x | 15.79x | 4.73x | 151.27x | 3.97x | 15.38x |
| Profitability | ||||||
| Gross Margin | 79.3% | 100.0% | 100.0% | 100.0% | 100.0% | -552.2% |
| Operating Margin | -504.1% | -101.9% | -60.0% | -4459.3% | -310.1% | -763.9% |
| Net Margin | -478.3% | -89.6% | -50.8% | -4434.7% | -298.4% | -746.7% |
| EBITDA Margin | -457.6% | -93.9% | -51.9% | -4182.1% | -286.1% | -723.5% |
| Liquidity | ||||||
| Current Ratio | 6.47x | 2.89x | 1.26x | 1.38x | 2.53x | 1.90x |
| Quick Ratio | 6.47x | 2.89x | 1.26x | 1.38x | 2.53x | 1.90x |
| Leverage | ||||||
| Debt/Equity | 0.03x | 0.12x | 0.81x | -0.83x | 0.92x | 0.32x |
YoY = year-over-year change. Source: FMP..